Potential conflict of interest
CM and BF applied for a patent on the clinical use of NPM1 mutants. The other authors report no potential conflicts of interest. Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal
Funding
This work was supported by grants from the Associazione Italiana Lotta alle Leucemie, Linfoma e Mieloma (AIL) Sezione ‘Luciano Pavarotti’ Modena-ONLUS and from the Associazione Italiana per la Ricerca sul Cancro [AIRC, IG 14797-2013].
Supplementary material available online
Molecular and immunohistochemical examinations including Supplementary Tables I and II.